Fortress Biotech, Inc. (NASDAQ:FBIO) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the Journey Medical's 2024 Financial Results and Corporate Update Conference Call.
Fortress Biotech Inc. (FBIO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 325,520 | $507,811 | +160% | 0.02% |
| 2. | 66,900 | $104,364 | -16% | 0% | |
| 3. | Renaissance Technologies Jim Simons | 32,000 | $49,920 | -82% | 0% |
| 4. | Citadel Investment Group Ken Griffin | 12,893 | $20,113 | -93% | 0% |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.84 | 763,359 | 3,657,264 | 2024-09-23 | Filing | ||
| $7.48 | 5,000 | Large Shareholder, Officer, Director | 127,500 | 2024-07-11 | Filing | |
| $7.50 | 500 | Officer | 500 | 2024-07-10 | Filing | |
| $7.39 | 5,000 | Large Shareholder, Officer, Director | 122,500 | 2024-07-09 | Filing | |
| $7.35 | 5,000 | Large Shareholder, Officer, Director | 117,500 | 2024-07-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.89 | 10,000 | Director | 53,400 | 2024-05-20 | Filing | |
| $2.45 | 5,000 | Director | 651,015 | 2021-12-28 | Filing | |
| $3.13 | 28,292 | Officer | 163,877 | 2021-09-21 | Filing | |
| $4.45 | 10,000 | Director | 720,000 | 2021-03-02 | Filing | |
| $4.31 | 8,000 | Director | 730,000 | 2021-02-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 752,551 | $1,173,979 | 0% | |
| 2. | 472,221 | $736,665 | 3.21% | |
| 3. | 292,481 | $456,270 | 0% | |
| 4. | 267,908 | $417,936 | 0% | |
| 5. | 237,534 | $370,585 | 0% |
News See All
5 Best Penny Stocks to Buy in September
Fortress Biotech, Inc. (NASDAQ:FBIO) is a New York-based company that develops and commercializes pharmaceutical and biotechnology products. On August 11, Fortress Biotech, Inc.
5 Best One Dollar Stocks To Buy Now
In this article, we discuss the 5 best one dollar stocks to buy today.
Hedge Funds Are Selling Fortress Biotech Inc (FBIO)
Is Fortress Biotech Inc (NASDAQ:FBIO) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors...
Is Fortress Biotech (FBIO) A Good Stock To Buy Now?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Here is What Hedge Funds Think About Fortress Biotech Inc (FBIO)
In this article we will check out the progression of hedge fund sentiment towards Fortress Biotech Inc (NASDAQ:FBIO) and determine whether it is a good investment right now.
Hedge Funds Have Never Been This Bullish On Fortress Biotech Inc (FBIO)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Fortress Biotech Inc (FBIO) Spike: Is It Deserved, And What's Next?
So here’s an example of just how inefficient the smaller end of the biotech sector can be.
A Look at Billionaire Paul Singer's Long-Term Investments
Activist investor and billionaire hedge fund manager Paul Singer was awarded this year's Manager Lifetime Achievement Award by the Institutional Investor magazine in New York in June.
Fortress Biotech Inc (FBIO)Hedge Funds Are Snapping Up
Is Fortress Biotech Inc (NASDAQ:FBIO) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Billionaire Hedge Funds
